Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.

PHARMACIE DES SALADELLES : revenue, balance sheet and financial ratios

PHARMACIE DES SALADELLES is a French company founded 13 years ago, specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé. Based in VAUVERT (30600), this company of category PME shows in 2024 a net income positive of 158 k€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-05-02

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Financial history - PHARMACIE DES SALADELLES (SIREN 752013912)
Indicator 2024 2023 2022 2022 2021 2020 2019 2018 2017
Revenue N/C N/C N/C N/C N/C N/C N/C N/C N/C
Net income 157 835 € 95 899 € 194 219 € -33 554 € 118 285 € 73 653 € 3 487 € 89 620 € 92 841 €
EBITDA N/C N/C N/C N/C N/C N/C N/C N/C N/C
Net margin N/C N/C N/C N/C N/C N/C N/C N/C N/C

Revenue and income statement

In 2024, PHARMACIE DES SALADELLES generates positive net income of 158 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2017-2024: 93 k€ -> 158 k€.

Net income (2024) ?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax

157 835 €

Loading income statement...

Chart evolution

Show :

Assets

Loading data...

Liabilities

Loading data...

Solvency and debt ratios

The debt ratio (= Financial debt / Equity x 100) stands at 92%. Debt level is high: negotiating margin with banks is reduced. Financial autonomy (= Equity / Total assets x 100) reaches 45%. This high autonomy means the company finances most of its assets through equity, a sign of strength.

Debt ratio (2024) ?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low
50-100% : Moderate
> 100% : High

91.697%

Financial autonomy (2024) ?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy
20-30% : Average
< 20% : Low

44.658%

Solvency indicators evolution
PHARMACIE DES SALADELLES

Sector positioning

Debt ratio
91.7 2024
2022
2023
2024
Q1: 16.46
Med: 58.47
Q3: 154.89
Average +15 pts over 3 years

In 2024, the debt ratio of PHARMACIE DES SALADELLES (91.70) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.

Financial autonomy
44.66% 2024
2022
2023
2024
Q1: 28.91%
Med: 49.95%
Q3: 69.47%
Average -14 pts over 3 years

In 2024, the financial autonomy of PHARMACIE DES SALADELLES (44.7%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.

Positioning of PHARMACIE DES SALADELLES in its sector

Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé

Valuation estimate

Based on 225 transactions of similar company sales in 2024, the value of PHARMACIE DES SALADELLES is estimated at 2 203 493 € (range 1 534 477€ - 3 296 552€). This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.

Estimated enterprise value 2024
225 transactions
1534k€ 2203k€ 3296k€
2 203 493 € Range: 1 534 477€ - 3 296 552€
NAF 5 année 2024

Valuation method used

Net Income Multiple
157 835 € × 14.0x = 2 203 493 €
Range: 1 534 478€ - 3 296 552€

Only this financial indicator is available for this company.

Valuation evolution

How is this estimate calculated?

This estimate is based on the analysis of 225 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.

  • EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
  • Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
  • Net Income Multiple: Relevant for mature companies with stable results.

This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).

Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)

Compare PHARMACIE DES SALADELLES with other companies in the same sector:

Voir toutes les statistiques du secteur Commerce de détail de produits pharmaceutiques en magasin spécialisé

Frequently asked questions about PHARMACIE DES SALADELLES

What is the revenue of PHARMACIE DES SALADELLES ?

The revenue of PHARMACIE DES SALADELLES is not publicly disclosed (confidential accounts filed with INPI).

Is PHARMACIE DES SALADELLES profitable?

Yes, PHARMACIE DES SALADELLES generated a net profit of 158 k€ in 2024.

Where is the headquarters of PHARMACIE DES SALADELLES ?

The headquarters of PHARMACIE DES SALADELLES is located in VAUVERT (30600), in the department Gard.

Where to find the tax return of PHARMACIE DES SALADELLES ?

The tax return of PHARMACIE DES SALADELLES is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does PHARMACIE DES SALADELLES operate?

PHARMACIE DES SALADELLES operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.